ERIS Lifesciences Stock Sees 5.28% Increase, Outperforms Sector by 3.04% on November 12

ERIS Lifesciences, a midcap pharmaceutical company, saw a 5.28% increase in its stock price on November 12, 2024. This rise was in line with the overall performance of the sector, as the company outperformed the sector by 3.04%. The stock has been on a consecutive gain for the last 3 days, with a total increase of 5.98% during this period.

On the day of November 12, ERIS Lifesciences reached an intraday high of Rs 1380.3, showing a 4.07% increase. The stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend.

In comparison to the Sensex performance, ERIS Lifesciences had a 1-day performance of 4.49%, while the Sensex had a -0.06% performance. Over the last month, ERIS Lifesciences had a performance of -0.01%, while the Sensex had a -2.37% performance.

ERIS Lifesciences is a midcap pharmaceutical company that focuses on providing high-quality and affordable medicines to patients. The company has been consistently performing well and has gained the attention of investors. However, it is important to note that this article is not making any recommendations or mentioning any potential for future growth. The information provided is based on facts and figures, and the stock call by MarketsMOJO is 'Hold'.